CONDENSED CONSOLIDATED STATEMENTS OF LOSS - USD ($) shares in Thousands	3 Months Ended	9 Months Ended
Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net product revenue	$ 7,014,000	$ 0	$ 8,510,000	$ 0
Cost of products sold	117,000	0	153,000	0
Gross profit	6,897,000	0	8,357,000	0
Operating expenses:
Research and development expenses	2,849,000	2,933,000	10,902,000	14,465,000
Selling, general and administrative expenses	39,158,000	14,096,000	110,404,000	57,535,000
Restructuring (income) expense	0	(69,000)	0	3,523,000
Total operating expense	42,007,000	16,960,000	121,306,000	75,523,000
Operating loss	(35,110,000)	(16,960,000)	(112,949,000)	(75,523,000)
Investment and other income, net	903,000	448,000	1,719,000	536,000
Interest expense	(1,978,000)	(3,564,000)	(7,532,000)	(9,087,000)
Loss on extinguishment of debt	0	0	(13,129,000)	0
Loss before income taxes	(36,185,000)	(20,076,000)	(131,891,000)	(84,074,000)
Income tax provision (benefit)	89,000	70,000	(401,000)	25,940,000
Net loss	$ (36,274,000)	$ (20,146,000)	$ (131,490,000)	$ (110,014,000)
Net loss per share - basic (in dollars per share)	$ (0.41)	$ (0.33)	$ (1.71)	$ (1.85)
Net loss per share - diluted (in dollars per share)	$ (0.41)	$ (0.33)	$ (1.71)	$ (1.85)
Weighted average number of shares outstanding - basic (in shares)	89,380	60,201	76,931	59,359
Weighted average number of shares outstanding - diluted (in shares)	89,380	60,201	76,931	59,359

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Name:	us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Total costs of sales and operating expenses for the period.